Form 4 for TTD Trade Desk (The)
Accepted 2024-10-02 00:00:00 ET · period of report 2024-09-30 · accession 0001671933-24-000107 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-10-02 | 2024-09-30+ | TTD | Green Jeffrey Terry | Pres, CEO, Dir, 10% | M - OptEx | $68.29 | +280.6K | 370.5K | +312% | +$19.17M |
| DM | 2024-10-02 | 2024-09-30+ | TTD | Green Jeffrey Terry | Pres, CEO, Dir, 10% | G - Gift | $0.00 | -280.6K | 146.5K | -66% | $0 |
| DMI | 2024-10-02 | 2024-09-30+ | TTD | Green Jeffrey Terry | Pres, CEO, Dir, 10% | G - Gift | $0.00 | +280.6K | 488.0K | +135% | $0 |
| DM | 2024-10-02 | 2024-09-30+ | TTD | Green Jeffrey Terry | Pres, CEO, Dir, 10% | M - OptEx | $0.00 | -280.6K | 18.45M | -1% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2024-10-02 | M | A | 56,649 | $68.29 | 203,150 | D | — | — | |
| 2 | Common | Class A Common Stock | 2024-09-30 | G | D | 224,000 | $0.00 | 146,501 | D See Footnote | — | — | (F2) Represents securities held by the Jeff Green Trust (the "Trust"). Mr. Green is a Trustee of the Trust and has investment and voting control over the shares held by the Trust, and may be deemed to indirectly beneficially own the shares held by the Trust. |
| 3 | Common | Class A Common Stock | 2024-09-30 | G | A | 224,000 | $0.00 | 431,330 | I | — | — | |
| 4 | Common | Class A Common Stock | 2024-09-30 | M | A | 224,000 | $68.29 | 370,501 | D See Footnote | — | — | (F2) Represents securities held by the Jeff Green Trust (the "Trust"). Mr. Green is a Trustee of the Trust and has investment and voting control over the shares held by the Trust, and may be deemed to indirectly beneficially own the shares held by the Trust. |
| 5 | Common | Class A Common Stock | 2024-10-02 | G | A | 56,649 | $0.00 | 487,979 | I | — | — | |
| 6 | Common | Class A Common Stock | 2024-10-02 | G | D | 56,649 | $0.00 | 146,501 | D | — | — | |
| 7 | Derivative | Employee Stock Option (Right to Buy) | 2024-09-30 | M | D | 224,000 | $0.00 | 18,505,850 | D | $68.29 · — to 2031-10-06 | 224,000 Class A Common Stock | (F5) The original target level of shares subject to this option was an aggregate of 16,000,000 shares; the actual number of shares of Class A Common Stock issuable upon vesting is subject to adjustment based on the greatest result of three tests tied to the stock price of the Issuer's Class A Common Stock relative to performance of the companies comprising the Nasdaq-100 Index as of the Grant Date and may range from 80% to 120% of the target level (12,800,000 to 19,200,000 shares in the aggregate). The number of awards shown of 18,505,850 is at the highest level of 19,200,000 net of 694,150 shares exercised through the Transaction Date. (F4) The shares subject to the option vest in eight tranches over a ten-year term beginning on October 6, 2021, (the "Grant Date"), and ending on October 6, 2031, (i) if the closing price of Issuer's Class A Common Stock measured over any 30-consecutive-trading-day period equals or exceeds $90.00, $115.00, $145.00, $185.00, $225.00, $260.00, $300.00 or $340.00, respectively, and (ii) for the first four years following the Grant Date, subject to continued service as the Issuer's Chief Executive Officer as of the applicable vesting date, and thereafter subject to continued service for the Issuer as of the applicable vesting date as Chief Executive Officer or in another role to be determined by the board of directors. |
| 8 | Derivative | Employee Stock Option (Right to Buy) | 2024-10-02 | M | D | 56,649 | $0.00 | 18,449,201 | D | $68.29 · — to 2031-10-06 | 56,649 Class A Common Stock | (F6) The original target level of shares subject to this option was an aggregate of 16,000,000 shares; the actual number of shares of Class A Common Stock issuable upon vesting is subject to adjustment based on the greatest result of three tests tied to the stock price of the Issuer's Class A Common Stock relative to performance of the companies comprising the Nasdaq-100 Index as of the Grant Date and may range from 80% to 120% of the target level (12,800,000 to 19,200,000 shares in the aggregate). The number of awards shown of 18,449,201 is at the highest level of 19,200,000 net of 750,799 shares exercised through the Transaction Date. (F4) The shares subject to the option vest in eight tranches over a ten-year term beginning on October 6, 2021, (the "Grant Date"), and ending on October 6, 2031, (i) if the closing price of Issuer's Class A Common Stock measured over any 30-consecutive-trading-day period equals or exceeds $90.00, $115.00, $145.00, $185.00, $225.00, $260.00, $300.00 or $340.00, respectively, and (ii) for the first four years following the Grant Date, subject to continued service as the Issuer's Chief Executive Officer as of the applicable vesting date, and thereafter subject to continued service for the Issuer as of the applicable vesting date as Chief Executive Officer or in another role to be determined by the board of directors. |